
Sheldon Lidofsky MD
Esophagus Disease, Inflammatory Bowel Disease, Malabsorption
Assistant Clinical Professor of Medicine, Brown University
Join to view full profile
33 Staniford St Providence, RIProvidence, RI 02905
Phone+1 401-421-8800
Fax+1 401-270-5935
Dr. Lidofsky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sheldon Lidofsky is a gastroenterologist based in Providence, RI, with subspecialties in esophagus disease, inflammatory bowel disease, and malabsorption. He completed his residency in internal medicine at Jacobi Medical Center/Albert Einstein College of Medicine and a fellowship in gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Lidofsky has expertise in conditions such as gastroesophageal reflux, ulcerative colitis, Crohn's disease, and esophageal disease. He has contributed to several publications on inflammatory bowel disease and related topics and has been the principal investigator for clinical trials on treatments for ulcerative colitis and Crohn's disease. His honors include CMS Meaningful Use Stage Certifications and recognition as a Regional Top Doctor by Castle Connolly.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 1979 - 1981
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1975 - 1979
State University of New York Downstate Medical Center College of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1978 - Present
RI State Medical License 1981 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification gGastro, gMed, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification gGastro, gMed, Inc., 2012, 2014-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) Start of enrollment: 2024 Jun 12
Roles: Principal Investigator
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease Start of enrollment: 2024 Apr 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- 6 citationsColorectal Kaposi Sarcoma in an Immunosuppressed Ulcerative Colitis Patient.Nishit Shah, Sheldon Lidofsky, Lisa Laskiewicz
Journal of Gastrointestinal Surgery. 2018-07-01 - 27 citationsIncidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.Jason Shapiro, Helga Zoega, Samir A. Shah, R Bright, Meaghan Mallette
Inflammatory Bowel Diseases. 2016-06-01 - 31 citationsBody Image Dissatisfaction in Patients with Inflammatory Bowel DiseaseSumona Saha, Ying-Qi Zhao, Samir A. Shah, Silvia Degli Esposti, Sheldon Lidofsky
Inflammatory Bowel Diseases. 2015-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









